Maria Patrizia Caldirola
Algemeen Directeur bij ClanoTech AB
Oorsprong van het eerstegraads netwerk van Maria Patrizia Caldirola
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
ClanoTech AB
ClanoTech AB Pharmaceuticals: MajorHealth Technology ClanoTech AB is a holding company that develops drugs for the treatment of cancer and macular degeneration. Its lead candidate is an inhibitor of the alpha5beta1-integrin receptor which is present in fibroblast and on vascular endothelial cells. Its Alpha5beta1-integrin is strongly up-regulated in fibroblast when switching to the fibrotic state and in scars after glaucoma surgery. Its strategy spans from therapeutic areas with high commercial potential as wet Age Regulated Macular Degeneration to ophthalmology niche indications with orphan drug opportunity such as developing advent in glaucoma surgery techniques. The company was founded by Yihai Cao in 2006 and is headquartered in Solna, Sweden.
1
| Holding Company | Pharmaceuticals: Major | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Statistieken
Internationaal
Zweden | 2 |
Denemarken | 2 |
Sectoraal
Consumer Services | 3 |
Operationeel
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Director/Board Member | 1 |
Founder | 1 |
Sterkste connecties
Insiders | |
---|---|
Yihai Cao | 3 |
- Beurs
- Insiders
- Maria Patrizia Caldirola
- Bedrijfsconnecties